Literature DB >> 11454143

Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered.

A Norlund1, J Apelqvist, P O Bitzén, P Nyberg, B Scherstén.   

Abstract

OBJECTIVE: To determine costs of illness for adult diabetes mellitus (DM), including complications caused by DM.
DESIGN: A population-based multicentre cross- sectional study including an interview and a physical examination of patients identified as having DM. The patients' medical records were analysed regarding diagnoses and complications attributable to DM.
SETTING: Eight health care centres of six primary care districts in Southern Sweden.
SUBJECTS: 1677 adults aged 25+, cared for at the health care centres, entered the study. MAIN OUTCOME MEASURES: Utilization of health care and care from relatives and the municipality, absence of short- and long-term sickness, cost of illness.
RESULTS: The average annual direct and indirect costs for an adult with DM were calculated to be 61 700 Swedish Kronor (SEK) or 2.5 times higher than earlier estimates. The incremental cost of DM was 34 100 SEK. The cost distribution was 28% for health care, 31% for the municipality and relatives and 41% lost productivity.
CONCLUSIONS: Calculations for the cost of illness of DM are underestimated if comorbidity caused by DM is not considered. When DM-related complications are included to identify the actual burden of disease to society, the cost of illness as a result of DM in Sweden is substantially higher than previously estimated.

Entities:  

Mesh:

Year:  2001        PMID: 11454143     DOI: 10.1046/j.1365-2796.2001.00852.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  20 in total

Review 1.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 2.  Cost-of-illness studies for bipolar disorder: systematic review of international studies.

Authors:  Huajie Jin; Paul McCrone
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

3.  Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data.

Authors:  Ulf-G Gerdtham; Philip Clarke; Alison Hayes; Soffia Gudbjornsdottir
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  Direct medical costs unequivocally related to diabetes in Italian specialized centers.

Authors:  Livio Garattini; Francesca Chiaffarino; Dante Cornago; Carlo Coscelli; Fabio Parazzini
Journal:  Eur J Health Econ       Date:  2004-02

Review 5.  Challenges in building disease-based national health accounts.

Authors:  Allison B Rosen; David M Cutler
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

6.  Validation of WHOQOL-BREF in Malayalam and Determinants of Quality of Life Among People With Type 2 Diabetes in Kerala, India.

Authors:  Aswathy Sreedevi; Sandhya Cherkil; Deepak Soman Kuttikattu; Leelamoni Kamalamma; Brian Oldenburg
Journal:  Asia Pac J Public Health       Date:  2015-09-29       Impact factor: 1.399

7.  Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study.

Authors:  M A Gershater; M Löndahl; P Nyberg; J Larsson; J Thörne; M Eneroth; J Apelqvist
Journal:  Diabetologia       Date:  2008-11-27       Impact factor: 10.122

Review 8.  The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.

Authors:  Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Layal Chaker; Sven J van der Lee; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Abby Falla; Raha Pazoki; Oscar H Franco
Journal:  Eur J Epidemiol       Date:  2015-01-18       Impact factor: 8.082

9.  Effectiveness of a Multicomponent Intervention in Primary Care That Addresses Patients with Diabetes Mellitus with Two or More Unhealthy Habits, Such as Diet, Physical Activity or Smoking: Multicenter Randomized Cluster Trial (EIRA Study).

Authors:  Francisco Represas-Carrera; Sabela Couso-Viana; Fátima Méndez-López; Bárbara Masluk; Rosa Magallón-Botaya; Jose I Recio-Rodríguez; Haizea Pombo; Alfonso Leiva-Rus; Montserrat Gil-Girbau; Emma Motrico; Ruth Martí-Lluch; Francisco Gude; Ana Clavería
Journal:  Int J Environ Res Public Health       Date:  2021-05-28       Impact factor: 3.390

10.  The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: a retrospective cross-sectional study using a national pharmacy claims database.

Authors:  Miriam O'Shea; Mary Teeling; Kathleen Bennett
Journal:  BMC Health Serv Res       Date:  2013-01-16       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.